Merck extends oncology and autoimmunity collaboration with BioMed X
Merck will launch an additional six research projects at the BioMed X Institute on top of its ongoing research projects
Read More
Tag: autoimmunity
- Oxford BioTherapeutics signs collaboration with Bristol Myers Squibb
- Kainova expands DT 7012 trial into Europe
- Amgen reports positive phase 3 results for subcutaneous TEPEZZA in thyroid eye disease
- CatalYm begins phase 2b trial of visugromab in second-line liver cancer treatment
- FDA approves new high dose Spinraza regimen for SMA
